Repurposing cardiac glycosides for anticancer treatment: a review of clinical studies
-
Published:2024-10
Issue:10
Volume:29
Page:104129
-
ISSN:1359-6446
-
Container-title:Drug Discovery Today
-
language:en
-
Short-container-title:Drug Discovery Today
Author:
Nik Nabil Wan Najbah,
Dai Rongchen,
Liu Mengfan,
Xi ZhichaoORCID,
Xu Hongxi
Reference59 articles.
1. A review of cardiac glycosides: structure, toxicokinetics, clinical signs, diagnosis and antineoplastic potential;Botelho;Toxicon,2019
2. Emergence of cardiac glycosides as potential drugs: current and future scope for cancer therapeutics;Kumavath;Biomolecules,2021
3. Toad venom: a comprehensive review of chemical constituents, anticancer activities, and mechanisms;Li;Arch Pharm,2021
4. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin;Cheng;Cancer Cell Int,2019
5. Meta-analysis of therapy of cinobufacini capsule adjunct with first-line platinum-based chemotherapy for the treatment of advanced NSCLC;Peng;Evid Based Complement Alternat Med,2021